Schering-Plough
SGP
#544
Rank
NZ$77.60 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Revenue for Schering-Plough (SGP)

Revenue in 2008: NZ$31.08 Billion

In 2008 the company made a revenue of NZ$31.08 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Schering-Plough from 1996 to 2008

Annual revenue

Year Revenue Change
2008NZ$31.08 B
2006NZ$17.79 B11.42%
2005NZ$15.97 B14.94%
2004NZ$13.89 B-0.74%
2003NZ$14.00 B-18.13%
2002NZ$17.10 B3.86%
2001NZ$16.46 B-0.13%
2000NZ$16.49 B6.96%
1999NZ$15.41 B13.61%
1998NZ$13.57 B19.16%
1997NZ$11.38 B19.84%
1996NZ$9.50 B